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Research
Asthma is a complex disease with both 
genetic and environmental components. The 
interaction between genetic predisposition 
and environmental factors is likely to have an 
important role in the etiology and prognosis 
of the disease. However, only few studies have 
addressed gene–environment interactions in 
asthma (Castro-Giner et al. 2006; London 
2007; Yang et al. 2008).
Air pollution contributes to the develop-
ment of asthma (Brauer et al. 2007; Gehring 
et al. 2002; Jacquemin et al. 2009; McConnell 
et al. 2006; Modig et al. 2006) and asthma 
exacerbations (D’Amato et al. 2005; Heinrich 
and Wichmann 2004; Künzli et al. 2000; Nel 
2005). Traffic-related pollutants such as par-
ticulate matter, nitrogen dioxide, and ozone 
are strong oxidants (D’Amato et al. 2005), 
leading to the production of reactive oxygen 
species (ROS). Oxidative stress triggers the 
inflammatory response and cytokine produc-
tion (Kelly 2003; Nel 2005). It is plausible 
that genetic variants involved in inflammation 
and protection against ROS may influence the 
response to air pollutants. Polymorphisms in 
oxidative stress genes NAD(P)H:quinine oxi-
doreductase [NQO1, GeneID 1728 (Entrez 
Gene 2008)] and gluthatione S-transferases 
M1 [GSTM1, GeneID 2944 (Entrez Gene 
2008)] and P1 [GSTP1, GeneID 2950 
(Entrez Gene 2008)] have been associated 
with a decrease on pulmonary function 
(Bergamaschi et al. 2001; Romieu et al. 2004; 
Yang et al. 2005) and with increased aller-
gic response (Gilliland et al. 2004, 2006), 
respiratory symptoms, and asthma (David 
et al. 2003; Lee et al. 2004; Li et al. 2006; 
Romieu et al. 2006) in response to air pol-
lutants, including O3 and diesel exhaust 
particles (DEP). Variants in the proinflam-
matory cytokine gene tumor necrosis factor α 
[TNFA, GeneID 7124 (Entrez Gene 2008)] 
have been linked to decrease in pulmonary 
function (Winterton et al. 2001; Yang et al. 
2005) and asthma and wheezing (Li et al. 
2006) in relation to O3 and sulfur dioxide 
exposure. A recent study using nitrogen 
oxides (NOx) as an indicator for local traffic 
air pollution has reported interaction effects 
between GSTP1 polymorphisms and NOx 
on allergic sensitization to common allergens 
in children at 4 years of age. This interaction 
was more pronounced in carriers of TNFA 
–308 GA or AA genotype (Melén et al. 
2008). Toll-like receptor 4 [TLR4, GeneID 
7099 (Entrez Gene 2008)], implicated in 
innate immunity and endotoxin responsive-
ness, is also a candidate to be involved in air 
pollution susceptibility (Romieu et al. 2008; 
Saxon and Diaz-Sanchez 2005; Yang et al. 
2008). In mouse models, lung hyperperme-
ability induced by O3 has been linked to the 
chromosome region containing the TLR4 
gene (Kleeberger et al. 2000, 2001). Another 
plausible candidate gene to modify the effects 
of air pollution is adrenergic receptor β2 
[ADRB2, GeneID 154 (Entrez Gene 2008)]. 
It has been shown that polymorphisms in 
this gene interact with environmental tobacco 
smoke in children (Wang et al. 2008; Zhang 
et al. 2007) and cigarette smoke in adults 
(Joos et al. 2003; Litonjua et al. 2004; Wang 
et al. 2001). However, a previous study evalu-
ating the combined effects of air pollutants 
and ADRB2 in children did not report signifi-
cant findings (Melén et al. 2008).
To date, evidence for gene–air pollution 
interactions on asthma have been reported 
only in children (Melén et al. 2008; Yang 
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Ba c k g r o u n d: Traffic-related air pollution is related with asthma, and this association may be 
modified by genetic factors.
oBjectives: We investigated the role of genetic polymorphisms potentially modifying the associa-
tion between home outdoor levels of modeled nitrogen dioxide and asthma.
Me t h o d s : Adults from 13 cities of the second European Community Respiratory Health Survey 
(ECRHS II) were included (n = 2,920), for whom both DNA and outdoor NO2 estimates were 
available. Home addresses were geocoded and linked to modeled outdoor NO2 estimates, as a 
marker of local traffic-related pollution. We examined asthma prevalence and evaluated polymor-
phisms in genes involved in oxidative stress pathways [gluthatione S-transferases M1 (GSTM1), 
T1 (GSTT1), and P1 (GSTP1) and NAD(P)H:quinine oxidoreductase (NQO1)], inflammatory 
response [tumor necrosis factor α (TNFA)], immunologic response [Toll-like receptor 4 (TLR4)], 
and airway reactivity [adrenergic receptor β2 (ADRB2)].
re s u l t s: The association between modeled NO2 and asthma prevalence was significant for carri-
ers of the most common genotypes of NQO1 rs2917666 [odds ratio (OR) = 1.54; 95% confidence 
interval (CI), 1.10–2.24], TNFA rs2844484 (OR = 2.02; 95% CI, 1.30–3.27). For new-onset 
asthma, the effect of NO2 was significant for the most common genotype of NQO1 rs2917666 (OR 
= 1.52; 95% CI, 1.09–2.16). A significant interaction was found between NQO1 rs2917666 and 
NO2 for asthma prevalence (p = 0.02) and new-onset asthma (p = 0.04).
co n c l u s i o n s: Genetic polymorphisms in the NQO1 gene are related to asthma susceptibility 
among persons exposed to local traffic-related air pollution. This points to the importance of anti-
oxidant pathways in the protection against the effects of air pollution on asthma.
key w o r d s : air pollution, asthma, gene polymorphisms, genetics, nitrogen dioxide, oxidative stress, 
traffic pollution. Environ Health Perspect 117:1919–1924 (2009).  doi:10.1289/ehp.0900589 avail-
able via http://dx.doi.org/ [Online 23 July 2009]Castro-Giner et al.
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et al. 2008). Susceptibility to air pollution in 
early life may biologically differ from adult-
hood (Salam et al. 2008). Previous analysis 
on the European Community Respiratory 
Health Survey (ECRHS) reported that traffic-
related pollution (using estimates of mod-
eled NO2 exposure) was positively associated 
with new-onset asthma in adults (Jacquemin 
et al. 2009). The aim of the present study 
was to identify interactions between genes 
and traffic-related pollution on asthma inci-
dence and prevalence in a large population-
based cohort (ECRHS) of adults. For this 
purpose, we evaluated previously reported 
candidate genes that have a role in oxidative 
stress {GSTM1, glutathione S-transferase T1 
[GSTT1, GeneID 2952 (Entrez Gene 2008)], 
GSTP1, and NQO1}, inflammatory response 
(TNFA), innate immunity (TLR4), and air-
way reactivity (ADRB2).
Materials and Methods
Study population. The methodology of 
ECRHS has been described elsewhere 
(Burney et al. 1994; ECRHS II Steering 
Committee 2002). Briefly, the ECRHS is 
a random   population-based multicenter 
cohort of subjects 20–44 years of age at the 
time of recruitment (1990; ECRHS I) and 
then followed approximately 10 years later in 
ECRHS II (median length of follow-up, 8.9 
years). In a first step of ECRHS I, random 
recruited subjects were contacted to complete 
a short questionnaire on respiratory symp-
toms. In a second step, a 20% random sample 
of participants was recontacted, completed 
a long questionnaire, and underwent some 
exams. A complementary sample of subjects 
with asthma symptoms at recruitment was also 
included in the study. Ethical approval was 
obtained for each center from the appropriate 
institutional ethics committee, and written 
consent was obtained from each participant.
For ECRHS II, modeled NO2 concentra-
tions were assigned to a total of 5,470 par-
ticipants in the 20 centers for which modeled 
air pollution was available. Genotyping was 
performed in 5,065 individuals from 19 cen-
ters, for which NO2 was measured for 2,920 
participants in 13 centers: Sweden (Umeå 
and Uppsala), United Kingdom (Ipswich 
and Norwich), Spain (Albacete, Barcelona, 
Huelva, Galdakao, and Oviedo), Germany 
(Erfurt), France (Paris and Grenoble), and 
Belgium (Antwerp). For the present analy-
sis, we excluded subjects from the symptom-
atic sample who did not report asthma in 
ECRHS II, leading to a final sample size of 
2,577. No major differences were observed 
between the complete sample with estimated 
NO2, the subsample with DNA, and the 
subsample with both DNA and NO2 [see 
Supplemental Material, Table 1 (doi:10.1289/
ehp.0900589.S1 via http://dx.doi.org)].
Subjects included in our analysis could be 
considered as mainly of European–Caucasian 
origin. The prevalence of asthma was based 
on a positive response to either of two ques-
tions in ECRHS II: attack of asthma during 
the last 12 months or current use of asthma 
medication. New-onset (incident) of asthma 
was defined as reporting asthma (either attack 
of asthma in preceding 12 months or cur-
rent medication for asthma) in ECRHS II 
(follow-up) excluding people who reported 
asthma (same definition as above) or a his-
tory of asthma in ECRHS I (baseline). 
Persistent asthma was defined as reporting 
asthma (either attack of asthma in preceding 
12 months or current medication for asthma) 
in both surveys.
We evaluated the robustness of our results 
with other definitions of asthma: ever asthma, 
defined as a positive response to “have you 
ever had asthma?” and physician-diagnosed 
asthma, defined as a positive response to “have 
you ever had asthma diagnosed by a doctor?” 
Participants also underwent a bronchial chal-
lenge with methacholine chloride adminis-
tered by Mefar aerosol dosimeters (Mefar, 
Bovezzo, Italy). Bronchial hyperresponsive-
ness was defined as a 20% fall in forced 
expiratory volume in 1 sec (FEV1) from the 
highest FEV1 postdiluent during methacho-
line challenge with an accumulated dose of 
1 mg (Burney et al. 1994; Chinn et al. 1997). 
Specific IgE levels to house dust mite, cat, 
timothy grass, and Cladosporium herbarum 
fungus were measured with the Pharmacia 
CAP system (Pharmacia Diagnostics, Uppsala, 
Sweden). Atopy was defined as sensitization 
(IgE levels > 0.35 kU/L) to any allergen.
Modeled NO2 concentrations. NO2 
has been widely used as a marker of local 
traffic-related air pollution (Emenius et al. 
2003; Forastiere et al. 2006; Jacquemin 
et al. 2009; Modig et al. 2006; Morgenstern 
et al. 2008). NO2 measurements substan-
tially differ within cities because they cap-
ture differences in exposure due to different 
proximities to traffic arteries. Details on mod-
eling of NO2 concentrations are described 
in the Supplemental Material (doi:10.1289/
ehp.0900589.S1). Briefly, as part of the Air 
Pollution Modelling for Support to Policy on 
Health and Environmental Risk in Europe 
project (APMoSPHERE  2007), 1-km- 
resolution emission maps were developed. 




frequency Coding change Variant
No. asthmatics 
(%) OR (95% CI)
GSTM1 Deletion 49.0 — Present 134 (12.0) 1.10 (0.8–1.54)
Null 152 (13.2) 1.06 (0.78–1.46)
GSTT1 Deletion 20.0 — Present 217 (12.0) 0.98 (0.78–1.26)
Null 69 (15.2) 1.69 (0.97–3.07)
GSTP1 rs1695 32.0 Exon 5 Ile105Val A/A 104 (11.2) 1.34 (0.97–1.93)
A/G+G/G 211 (14.1) 1.10 (0.84–1.46)
NQO1 rs10517 11.9 3´ UTR region C/C 131 (14.1) 1.20 (0.96–1.53)
C/T+T/T 193 (11.8) 1.11 (0.71–1.82)
NQO1 rs1800566 20.2 Exon 6 Pro187Ser C/C 222 (12.7) 1.36 (1.03–1.84)
C/T+T/T 102 (12.5) 1.06 (0.79–1.45)
NQO1 rs2917666 32.2 3´ downstream C/C 163 (12.8) 1.54 (1.10–2.24)
C/G+G/G 164 (12.7) 1.01 (0.79–1.33)
TLR4 rs10759930 40.1 5´ upstream C/C 143 (13.5) 1.13 (0.80–1.65)
C/T+T/T 163 (12.3) 1.21 (0.95–1.58)
TLR4 rs11536889 14.3 3´ UTR region G/G 255 (12.9) 1.22 (0.96–1.58)
G/C+C/C 72 (12.3) 1.24 (0.83–1.98)
TLR4 rs1554973 23.7 3´ downstream T/T 207 (12.5) 1.19 (0.91–1.58)
T/C+C/C 119 (13.0) 1.19 (0.87–1.66)
TLR4 rs1927914 32.5 5´ UTR region T/T 155 (12.9) 1.20 (0.89–1.65)
T/C+C/C 171 (12.5) 1.18 (0.90–1.58)
TLR4 rs2737191 27.3 5´ upstream A/A 115 (12.4) 1.28 (0.96–1.73)
A/G+G/G 212 (13.0) 1.10 (0.82–1.49)
TNFA rs1800629 16.1 5´ upstream  G/G 207 (12.0) 1.27 (0.97–1.69)
G/A+A/A 69 (11.1) 1.22 (0.86–1.80)
TNFA rs2844484 41.2 5´ upstream C/C 196 (13.1) 2.02 (1.30–3.27)
C/T+T/T 131 (12.2) 1.02 (0.81–1.30)
TNFA rs909253 31.2 Intron 3 of LTA A/A 146 (12.4) 1.29 (0.96–1.76)
A/G+G/G 180 (13.0) 1.14 (0.86–1.54)
ADRB2 rs1042713 38.8 Exon 1 Arg16Gly G/G 166 (12.3) 1.03 (0.73–1.50)
G/A+A/A 160 (13.2) 1.18 (0.91–1.56)
ADRB2 rs1042714 40.0 Exon 1 Gln27Glu C/C 197 (12.0) 1.21 (0.88–1.70)
C/G+G/G 102 (14.9) 1.20 (0.92–1.60)
ADRB2 rs1042718 17.7 Exon 1 synonymous C/C 115 (12.3) 1.21 (0.94–1.57)
C/A+A/A 212 (12.9) 1.20 (0.79–1.65)
ADRB2 rs1042719 30.4 Exon 1 synonymous G/G 147 (12.0) 1.23 (0.92–1.68)
G/C+C/C 180 (13.4) 1.19 (0.89–1.63)Asthma, air pollution, and genetic polymorphisms
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The NO  x emission map was used as the basis 
for modeling NO2 concentrations using focal 
sum techniques in a global information sys-
tem model. The NO2 at the place of residence 
for each subject was then obtained by inter-
secting the point locations of their residence 
with the air pollution map.
DNA extraction and genotype characteriza-
tion. Polymorphisms of the genes GSTM1, 
GSTT1, and GSTP1 were selected accord-
ing to functional evidence from existing lit-
erature. For the genes NQO1, TNFA, TLR4, 
and ADRB2, we selected tag single-nucleotide 
polymorphisms (SNPs) in the gene region, 
10 kb upstream from the 5´ untranslated 
region (UTR), and 10 kb downstream from 
3´ UTR. Polymorphisms are listed in Table 1.
DNA was extracted from blood cells for 
samples using a commercially available kit 
(Puregene, Gentra Inc., MN, USA). The 
DNA bank was built and maintained at 
Helmholtz Zentrum München in Germany. 
Genotyping was performed at the Centre for 
Genomic Regulation in the Barcelona Node 
of the Centro Nacional de Genotipado (2009) 
in Spain. GSTM1 and GSTT1 genotypes were 
determined using polymerase chain reaction 
method and GSTP1 polymorphism by spe-
cific pyrosequencing assay. Genotyping for 
NQO1, TNFA, and TLR4 polymorphisms 
was performed using the SNPlex platform 
(Applied Biosystems, Foster City, CA, USA). 
The average genotyping rate was 98%.
Statistical analysis. The statistical analy-
ses were performed using logistic regression 
implemented in the SNPassoc (version 1.5) 
(Gonzalez et al. 2007) package in R (ver-
sion 2.6.1; R Foundation for Statistical 
Computing, Vienna, Austria). Generalized 
additive models (GAMs) were used to evalu-
ate dose–response relationships with NO2. 
Logistic models and GAMs were adjusted 
for center, sex, age, environmental tobacco 
smoke, and smoking status. Multiplicative 
interactions were assessed using likelihood-
ratio test comparing models with additive 
term and interaction term. Heterogeneity was 
evaluated using the Mantel–Haenszel method 
under fixed-effects model with the R library 
rmeta package (version 2.14). Logistic mixed-
effects models allowed the evaluation of a 
random effect of the variable center. These 
models were also adjusted for the previously 
described covariates.
We tested deviations of genotype fre-
quencies from Hardy–Weinberg equilibrium 
(HWE) (Wigginton et al. 2005) in the ran-
domly selected population. To check the inde-
pendence of the polymorphisms, we estimated 
the correlation (R2) and linkage disequilibrium 
coefficient (D´). Haplotypes were estimated 
using the haplo.em function from the haplo.
stats package (version 1.3.8) (Schaid et al. 
2002). Population stratification was assessed 
with the analysis of 26 unlinked markers [see 
Supplemental Material, Table 2 (doi:10.1289/
ehp.0900589.S1)] using two different meth-
ods. First, the genomic control approach 
(Devlin and Roeder 1999) showed a minimal 
effect [inflation factor (λ) = 1.06]. Second, 
principal component analysis using the 
EIGENSTRAT method (version 1.01) (Price 
et al. 2006) showed no evidence of popula-
tion stratification [see Supplemental Material, 
Figure 1 (doi:10.1289/ehp.0900589.S1)].
Additional information on material and 
methods can be found in the Supplemental 
Material (doi:10.1289/ehp.0900589.S1).
Results
Table 2 lists population characteristics. The 
prevalence of current asthma in this sam-
ple was 12.7% (n = 327). Compared with 
subjects without asthma, asthmatics more 
often were women, were younger, reported 
less smoking, and had lower percentage of 
predicted lung function. Distribution of 
NO2 was similar to the previously reported 
for the whole population (Jacquemin et al. 
2009) [see Supplemental Material, Table 3 
(doi:10.1289/ehp.0900589.S1)]. The mul-
tivariate analysis of NO2 and prevalence of 
asthma indicates a small but not significant 
increase in asthma for each 10-µg/m3 increase 
in NO2 [odds ratio (OR) = 1.19; 95% confi-
dence interval (CI), 0.97–1.47]. We observed 
departure from the HWE for GSTP1 rs16951 
(p < 0.01). Allele distribution by center was 
heterogeneous for TNFA rs2844484 and 
TNFA rs909253 variants (p < 0.01).
For each genetic polymorphism, we 
evaluated the association between NO2 (per 
10-µg/m3 increase) and asthma prevalence 
separately for carriers of the minor allele 
(either homozygous or heterozygous) and for 
the subjects homozygous for the major allele 
(Table 1). We found no statistically signifi-
cant associations between NO2 and asthma 
for any of the genotypes of GSTM1, GSTT1, 
GSTP1, TLR4, and ADRB2 genes. The asso-
ciation between prevalence of asthma and 
NO2 was significant for subjects homozygous 
for the major allele of NQO1 rs2917666 (OR 
= 1.54; 95% CI, 1.10–2.24) and for TNFA 
rs2844484 (OR = 2.02; 95% CI, 1.30–3.27). 
A test for interaction between these poly-
morphisms and NO2 was significant only for 
NQO1 rs2917666 (p-value for interaction = 
0.02). Analysis using GAMs (Figure 1) indi-
cated a significant linear increase in preva-
lence for homozygotes of the most prevalent 
alleles in NQO1 rs2917666 (p = 0.02) and no 
increase for the G/C and G/G genotypes.
We further performed the haplo-
type analy  sis for the three SNPs of NQO1 
(rs10517, rs1800566, and rs2917666) in 
relation to NO2 exposure and prevalence of 
asthma (Table 3). In this analysis, we provide 
Figure 1. Spline graphics using GAM for the association between NO2 and current asthma, stratified by 
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Table 2. Population characteristics at follow-up (ECRHS II) for subjects with both DNA and assigned 
levels of NO2.
All No asthma Asthma p-Value
Subjects (no.) 2,577 2,250 327 —
Females [no. (%)] 1,345 (52.2) 1,154 (51.3) 191 (58.4) 0.02
Age [years (mean ± SD)] 43.03 ± 7.3 43.2 ± 7.2 41.83 ± 7.2 0.001
Smoking status [no. (%)]
 Never 1,130 (44) 969 (43.1) 161 (49.2) —
 Former 714 (27.8) 624 (27.8) 90 (27.5) —
 Current 729 (28.3) 653 (29.1) 76 (23.2) 0.05
Same house during follow-up [no. (%)] 1,348 (52.3) 1,192 (53.0) 156 (47.7) 0.08
Percent predicted FEV1 (mean ± SD) 106.81 ± 15.2 108.86 ± 13.9 95.58 ± 18.2 < 0.001Castro-Giner et al.
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estimates for exposure among subjects within 
combinations of SNPs. Linkage disequilib-
rium was weak between some of the NQO1 
SNPs (D´ = 0.97, r2 = 0.03, and p < 0.01 
between rs10517 and rs1800566; D´ = 0.86, 
r2 = 0.21, and p < 0.01 between rs10517 
and rs2917666; D´ = 0.99, r2 = 0.53, and 
p < 0.01 between rs1800566 and rs2917666). 
The association between asthma prevalence 
and NO2 was significant for the most preva-
lent haplotype, composed of the three major 
alleles of each SNP (OR = 1.23; 95% CI, 
1.03–1.48). This was the only haplotype 
containing the C allele of rs2917666, which 
showed a significant interaction with NO2 
in the single SNP analysis. We observed no 
significant associations among carriers of the 
other haplotypes (Table 3).
We also analyzed longitudinal data to 
evaluate the effect of NO2 on new-onset 
asthma. We observed a significant association 
between new-onset asthma and NO2 levels 
for the 120 subjects who developed asthma 
during the follow-up period (OR = 1.52; 95% 
CI, 1.09–2.16). Subjects homozygous for the 
NQO1 rs291766 C allele were at greater risk 
(p-value for interaction = 0.04) for develop-
ing asthma (OR = 2.02; 95% CI, 1.16–3.73) 
compared with those with CG/GG genotypes 
(OR = 1.26; 95% CI, 0.83–1.99).
We restricted the analysis to those subjects 
who lived in the same home during follow-up 
(n = 1,348) to reduce exposure misclassifica-
tion. Compared with subjects who changed 
homes, this group had an increased risk for 
main effects of exposure to NO2 on asthma 
prevalence (movers: OR = 1.64; 95% CI, 
1.08–2.53; nonmovers: OR = 1.02; 95% CI, 
0.80–1.31; p-value for interaction = 0.03), 
whereas the effect on new-onset asthma was 
not different between movers and nonmov-
ers (movers: OR = 1.48; 95% CI, 0.83–2.74; 
nonmovers: OR =1.59; 95% CI, 1.05–2.52; 
p-value for interaction = 0.81). CC carriers of 
NQO1 rs2917666 living in the same home 
during follow-up had an increased risk for 
prevalence (OR = 2.42; 95% CI, 1.19–5.24) 
and new-onset asthma (OR = 2.89; 95% CI, 
1.02–9.46).
In a sensitivity analysis, we also evaluated 
our findings of interaction between NQO1 
rs2917666 and NO2 for other asthma defi-
nitions and asthma-related phenotypes [see 
Supplemental Material, Table 4 (doi:10.1289/
ehp.0900589.S1)]. Interaction was signifi-
cant for ever asthma (p = 0.006), physician-
diagnosed asthma (p = 0.01), and asthmatics 
showing bronchial hyperresponsiveness (p = 
0.02), whereas interactions were not significant 
for persistent asthma (p = 0.12) or atopy (p = 
0.46). Stratification by atopic status showed 
that interaction between NO2 and NQO1 
rs2917666 was more pronounced among non-
atopic carriers of NQO1 rs2917666 C/C (OR 
= 2.38; 95% CI, 1.13–5.68; p-value for inter-
action = 0.01) compared with atopic subjects 
(OR = 1.24; 95% CI, 0.84–1.91; p-value for 
interaction = 0.45).
When stratified by sex [see Supplemental 
Material, Table 5 (doi:10.1289/ehp.0900589.
S1)], interaction between NO2 and rs2917666 
was significant only among females (C/C: OR 
= 1.81; 95% CI, 1.13–3.09; p-value for inter-
action = 0.03) and not in males (C/C: OR = 
1.39; 95% CI, 0.82–2.46; p-value for inter-
action = 0.24). However, heterogeneity by gen-
der was not significant (p = 0.71). We observed 
no significant differences in the effect of NO2 
and NQO1 rs2917666 on current asthma by 
center (p-value for heterogeneity = 0.51). In 
addition, after including the random effects 
of center in a generalized mixed model, the 
interaction of NO2 and NQO1 rs2917666 was 
still significant for the prevalence of asthma 
(p-value for interaction = 0.02). Heterogeneity 
was not significant among different socioeco-
nomic strata based on occupation (p-value for 
heterogeneity = 0.28). The exclusion of non-
randomly selected symptomatic subjects in the 
second step of ECRHS I did not modify the 
effects observed in the whole sample (p-value 
for heterogeneity = 0.36)
Discussion
We evaluated the effect of genes involved in 
oxidative stress pathways (GSTM1, GSTT1, 
GSTP1, and NQO1), inflammatory response 
(TNFA), immunologic response (TLR4), and 
airway reactivity (ADRB2) on the association 
of traffic-related air pollution (using estimates 
of modeled NO2 exposure) and adult asthma 
in a large, multicenter population-based cohort. 
We observed stronger associations between 
NO2 concentrations and both prevalent and 
new-onset asthma among subjects homozy-
gous for the most common allele of NQO1 
compared with carriers of NQO1 variants. 
Although several studies have evaluated simi-
lar gene–  environment interactions in children 
(Bergamaschi et al. 2001; David et al. 2003; Lee 
et al. 2004; Li et al. 2006; Melén et al. 2008; 
Romieu et al. 2004, 2006) and in experimental 
settings in adults (Corradi et al. 2002; Gilliland 
et al. 2004, 2006; Winterton et al. 2001; Yang 
et al. 2005), this is the first study examining the 
interaction of genetic variation and long-term 
air pollution on asthma in adults.
Similar to other studies, we used NO2 
level as a marker of traffic-related air pollution 
(Emenius et al. 2003; Forastiere et al. 2006; 
Jacquemin et al. 2009; Melén et al. 2008; 
Modig et al. 2006; Morgenstern et al. 2008). 
Thus, the observed associations and interactions 
may be mediated by other ambient air pollut-
ants, which are highly spatially correlated with 
NO2. However, NO2 is a strong oxidant per se, 
with a range of well-known adverse effects 
(Forastiere et al. 2006; Janssen-Heininger et al. 
2002), and NO2 either alone or combined with 
other pollutants may contribute to the observed 
effects (Forastiere et al. 2006).
In our study, we found a nonsignificant 
reduction of the NO2 effects among carriers 
of at least one NQO1 Ser187 allele. The poly-
morphism that was associated with the most 
significant p-value in our study (rs2917666) 
is not known to be functional but is located in 
the 5´ upstream region of the gene. This region 
contains elements essential for the expression 
and induction of NQO1, such as the anti-
oxidant response element that is required for 
NQO1 transcription in response to oxidative 
stress (Jaiswal 2000; Nioi and Hayes 2004). 
The three SNPs in the NQO1 gene were in 
relatively weak linkage disequilibrium with 
the highest r2 (0.53) found for the functional 
Pro187Ser (rs1800566) and rs2917666. 
Furthermore, the association between asthma 
and modeled NO2 was significant for the most 
prevalent haplotype that contained the C allele 
of the rs2917666, which showed a significant 
interaction with NO2 in the single SNP analy-
sis. A few studies have evaluated the role of 
NQO1 in relation to exposure to O3 [reviewed 
by Yang et al. (2008)] and have shown that the 
Pro187Ser (rs1800566) polymorphism was 
protective in response to O3 when GSTM1 
was present (Bergamaschi et al. 2001; Corradi 
et al. 2002; David et al. 2003). Susceptibility 
variants on oxidative stress genes GSTM1 and 
GSTP1 have been associated with an increased 
effect of air pollution and specific pollutants 
(Gilliland et al. 2004; Lee et al. 2004; Li et al. 
2006; Melén et al. 2008; Romieu et al. 2004, 
2006). In this study, we did not observe sig-
nificant associations of GSTM1 or GSTP1 
polymorphisms with asthma either alone or 
in combination with NQO1 SNPs. Lack of 
consistence with previous analyses could be 
related to the heterogeneity of effects in adults 
compared with children (Salam et al. 2008).
Our findings on NQO1 reinforce the 
role of antioxidant system in response to air 
pollution (Kelly 2003; Romieu et al. 2008). 
An in vitro approach proposed a hierarchi-
cal model to explain the dose-dependent 
Table 3. Association of NO2 per 10-µg/m3 increase and asthma prevalence stratified by NQO1 and haplo-
types in ECRHS II.
Haplotype
Allele
Prevalence OR (95% CI) p-Value
p-Value for 
interaction rs10517 rs1800566 rs2917666
1 C C C 0.66 1.23 (1.03–1.48) 0.03 Reference
2 C T G 0.21 1.28 (0.90–1.89) 0.20 0.50
3 T C G 0.11 1.11 (0.72–1.81) 0.66 0.73Asthma, air pollution, and genetic polymorphisms
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response to oxidant chemicals in DEP (Xiao 
et al. 2003) that will probably extend to gas-
eous pollutants like NO2 (Saxon and Diaz-
Sanchez 2005). With low exposure, the 
formation of ROS activates the transcription 
of genes involved in antioxidant responses, 
such as phase II enzymes (e.g., NQO1 and 
GST genes). Higher exposure activates the 
transcription of nuclear factor-κB and activa-
tor protein-1, resulting in increased expression 
of proinflammatory cytokines (e.g., TNF-
α), leading to additional generation of ROS 
(Romieu et al. 2008; Saxon and Diaz-Sanchez 
2005).
The ECRHS is a large population-based 
international cohort that overcomes limi-
tations of studies done in selected popula-
tions. The main limitations of this analysis 
include limited statistical power to detect 
interactions, some exposure misclassification, 
and heterogeneity and potential confound-
ing concerning environmental exposures and 
genetic variation.
Statistical power to detect interactions 
was relatively low (Garcia-Closas et al. 1999). 
False-positive results have been shown to be 
frequent in studies on genetic variation and 
gene–environment interactions (Clayton and 
McKeigue 2001), and for these reason these 
results should be interpreted with caution. 
In this study we did not perform correction 
for multiple comparisons. However, tradi-
tional methods based on Bonferroni are over-
conservative because polymorphisms within a 
gene are not completely independent due to 
linkage disequilibrium. In addition, this cor-
rection may be acceptable when searching for 
significant associations without preestablished 
hypotheses, but we selected genes in this 
analy  sis on the basis of strong prior evidence.
Strengths and limitations of the NO2 
exposure assessment have been discussed previ-
ously (Jacquemin et al. 2009). The individual 
assignment of exposure to NO2 should result 
in a reduction of exposure misclassification. 
We evaluated NO2 exposure by geo  coding 
home addresses of ECRHS participants and 
assigned ambient modeled NO2 concentra-
tion derived from the APMoSPHERE map 
to each subject. The year of modeled NO2 
(2001) was concordant with the years of the 
administration of the ECRHS II question-
naire (1999–2002). However, the spatial scale 
of the APMoSPHERE model was relatively 
broad (1 × 1 km), and the model did not 
include monitors placed close to traffic. Thus, 
spatial and temporal contrasts in exposure 
due to very local emissions and dispersion 
patterns, such as those occurring in street can-
yons are unlikely to be captured. NO2 does 
also capture part of that space but as a sec-
ondary gas is certainly more homogeneously 
distributed than, for example, ultrafine tail 
pipe particles. The misclassification is random 
in nature so, if anything, some bias toward the 
null may be expected. If those local peak con-
centrations were particularly relevant sources 
of exposure to oxidants, the APMoSPHERE-
based results would likely underestimate true 
effects and interactions.
Because of the lack of repeated mea-
surements during follow-up, exposure was 
assigned only to residences in ECRHS II. 
Although levels of air pollution did not 
remain constant during the follow-up period, 
the ranking in the spatial distribution of 
traffic-related pollutants is likely to remain 
similar. Exposure misclassification is thus par-
ticularly large among those who moved after 
ECRHS I, possibly explaining the smaller 
effects observed among movers (Beelen et al. 
2008; Gotschi et al. 2008a).
Levels of air pollution and prevalence of 
asthma varied substantially across centers in 
ECRHS, showing a south–north gradient 
(Gotschi et al. 2008b; Jacquemin et al. 2009; 
Sunyer et al. 2004). Median levels of mod-
eled NO2 varied from 12 µg/m3 in Umeå to 
more than 50 µg/m3 in Barcelona and Paris 
(Jacquemin et al. 2009). Variables correlated 
with center, such as pollution composition, cli-
matic factors, and diet, determine the individ-
ual response to air pollution (D’Amato et al. 
2005). All results were adjusted by center, 
and random-effects meta-analysis suggested 
that NO2 estimates and interactions with the 
genes were not center specific, although we 
acknowledge the limited power to detect this 
heterogeneity. In addition, recent analyses of 
population stratification among Europeans 
found correspondence between genetic varia-
tion and geographic distances, although lev-
els of genetic diversity were low (Heath et al. 
2008). Previous analyses in the ECRHS have 
shown little evidence of population stratifica-
tion (Castro-Giner et al. 2008). However, this 
was based on an insufficient set of markers.
An important source of NO2 exposure in 
the general population originates from the use 
of gas cookers (D’Amato et al. 2005). Several 
studies reported the association of indoor 
exposures with NO2 outcomes and respiratory 
or allergic outcomes (Bernstein et al. 2008). 
In our data, outdoor NO2 was not correlated 
with gas cooking, and adjustment for cooking 
with gas did not affect the observed effects 
of outdoor NO2 and its interaction with the 
NQO1 polymorphism.
Differences were observed by sex, with 
females showing an increase in risk. However, 
the sample sizes of specific strata are smaller 
than the total population, and interpretation 
of these results should be done with caution. 
Our findings, if corroborated by others, may 
have significant public health implications 
because we identified a large group of suscep-
tible subjects defined by the genetic makeup 
for whom the effect of modeled NO2-related 
air pollution on asthma was substantial. The 
affected subgroup was large, with a 46% 
prevalence of the C/C genotype for NQO1 
rs2917666. Moreover, the number of people 
exposed to traffic-related pollution on a regu-
lar basis is large and as a consequence the bur-
den of asthma related to ambient air pollution 
may be large not only in children, as previ-
ously documented, but also in adults.
Conclusions
Findings from this study suggest that genetic 
polymorphisms in the NQO1 gene are associ-
ated with susceptibility to asthma in adults 
among those exposed to traffic-related air pol-
lution. This result points to the importance 
of antioxidant pathways in the effects of air 
pollution on asthma.
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